End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0135 USD | +12.50% | -32.50% | -89.07% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | +12.50% | ||
1 week | -32.50% | ||
Current month | -15.62% | ||
1 month | -55.00% | ||
3 months | -32.50% | ||
6 months | -77.57% | ||
Current year | -89.07% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 1,487 M€ | +7.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 0.0135 | +12.50% | 60,535 |
24-05-13 | 0.012 | -11.11% | 21,564 |
24-05-10 | 0.0135 | -3.57% | 102,967 |
24-05-09 | 0.014 | +3.70% | 299,361 |
24-05-08 | 0.0135 | -32.50% | 52,278 |
End-of-day quote OTC Markets, May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-89.07% | 7.34M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.52% | 21.25B | |
-5.71% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- SRNE Stock